laboratories performing the test can bill Medicare and other health insurers for services after February 4, 2020, using HCPCS code (U0001),(U0002)
-curve(curve);
2020-3-30{45}(#12813525@0)+2
March 18, 2020, Congress passed the Families First Coronavirus Response Act making testing for COVID-19 completely free.
-curve(curve);
2020-3-30(#12813835@0)+2
March 16, 2020 - Following the development of new billing codes, CMS is now letting clinical laboratories know how much they will receive in Medicare reimbursement for testing patients for COVID-19.
CMS emailed providers last week with a pricing list for COVID-19 diagnostic tests. The list stated that laboratories testing patients for the novel coronavirus using the CDC’s test will receive about $36 in Medicare reimbursement, while those non-CDC test kits will receive about $51.
However, CMS pointed out in the email that “prices may vary slightly depending on the local Medicare Administrative Contractor (MAC).”
Local Medicare Administrative Contractors (MACs) are responsible for developing the payment amount for claims they receive for these newly created HCPCS codes in their respective jurisdictions until Medicare establishes national payment rates.
-blanc(no matter what);
2020-3-31(#12818216@0)
